HVC
GSK icon

Healthcare Value Capital’s GSK GSK Stock Holding History

Healthcare Value Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-40,000
Closed -$2.03M – 29
2016
Q1 		$2.03M Hold
40,000
– – 2.98% 11
2015
Q4 		$2.02M Sell
40,000
-40,000
-50% -$2.04M 3.34% 9
2015
Q3 		$3.85M Buy
+80,000
New +$4.16M 5.48% 8
2013
Q3 		– Sell
-20,000
Closed -$1.25M – 55
2013
Q2 		$1.25M Buy
+20,000
New +$1.27M 0.91% 38

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare Value Capital's GSK Position: Q3 2021 in Review

Healthcare Value Capital held its GSK (GSK) position steady in Q3 2021 at 80,000 shares worth $3.82M. The position accounts for 7.54% of the portfolio, ranked #2.

Healthcare Value Capital first reported a position in GSK in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.8M in Q2 2019. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Healthcare Value Capital held 80,000 shares of GSK worth $3.82M as of Q3 2021.
  • Healthcare Value Capital left its GSK share count unchanged in Q3 2021.
  • GSK made up 7.54% of Healthcare Value Capital's portfolio in Q3 2021, its #2 holding.
  • Healthcare Value Capital first reported a position in GSK in Q2 2013 and has held it in 20 quarters since.
  • Healthcare Value Capital's GSK position peaked at $4.8M in Q2 2019.
  • 793 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.